Archives of Pediatric Infectious Diseases

Published by: Kowsar

New Advances in Diagnosis of Latent Tuberculosis Infection: A Review Article

Masoud Mardani 1 and Zahra Abtahian 1 , *
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center , Shahid Beheshti University of Medical Sciences,Tehran, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: January 01, 2015, 3 (1 TB); e22368
  • Published Online: January 25, 2015
  • Article Type: Review Article
  • Received: August 2, 2014
  • Revised: August 25, 2014
  • Accepted: September 4, 2014
  • DOI: 10.5812/pedinfect.22368

To Cite: Mardani M, Abtahian Z. New Advances in Diagnosis of Latent Tuberculosis Infection: A Review Article, Arch Pediatr Infect Dis. 2015 ; 3(1 TB):e22368. doi: 10.5812/pedinfect.22368.

Abstract
Copyright © 2015, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Purposeful Detection of Tuberculosis
3. Detection of Latent Tuberculosis Infection
4. Latent Tuberculosis Infection and Disease Differentiation
5. Diagnosis of Latent Tuberculosis Infection
6. Selecting a Test to Detect Tuberculosis Infection
7. Contacts
8. Pregnancy
9. Discussion
Acknowledgements
Footnote
References
  • 1. Kondratieva T, Azhikina T, Nikonenko B, Kaprelyants A, Apt A. Latent tuberculosis infection: What we know about its genetic control? Tuberculosis. 2014; [DOI]
  • 2. Shim TS. Diagnosis and Treatment of Latent Tuberculosis Infection due to Initiation of Anti-TNF Therapy. Tuberc Respir Dis (Seoul). 2014; 76(6): 261-8[DOI][PubMed]
  • 3. Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA. 2005; 293(22): 2767-75[DOI][PubMed]
  • 4. Dye C, Williams BG. Eliminating human tuberculosis in the twenty-first century. J R Soc Interface. 2008; 5(23): 653-62[DOI][PubMed]
  • 5. Ahmad S. New approaches in the diagnosis and treatment of latent tuberculosis infection. Respir Res. 2010; 11: 169[DOI][PubMed]
  • 6. CDC . Latent Tuberculosis Infection: A Guide for Primary Health Care Providers. 2013;
  • 7. Esmail H, Barry CE, 3rd, Wilkinson RJ. Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies. Drug Discov Today. 2012; 17(9-10): 514-21[DOI][PubMed]
  • 8. Huebner RE, Schein MF, Bass JJ. The tuberculin skin test. Clin Infect Dis. 1993; 17(6): 968-75[PubMed]
  • 9. Pesanti EL. The negative tuberculin test. Tuberculin, HIV, and anergy panels. Am J Respir Crit Care Med. 1994; 149(6): 1699-709[DOI][PubMed]
  • 10. Kritzinger FE, Den Boon S, Verver S, Enarson DA, Lombard CJ, Borgdorff MW, et al. No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Tropic Medic Inter Health. 2009; 14(2): 136-42
  • 11. Linas BP, Wong AY, Freedberg KA, Horsburgh CR, Jr. Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med. 2011; 184(5): 590-601[DOI][PubMed]
  • 12. Bearman JE, Kleinman H, Glyer VV, Lacroix OM. A Study of Variability in Tuberculin Test Reading. Am Rev Respir Dis. 1964; 90: 913-9[PubMed]
  • 13. Chaparas SD, Vandiviere HM, Melvin I, Koch G, Becker C. Tuberculin test. Variability with the Mantoux procedure. Am Rev Respir Dis. 1985; 132(1): 175-7[PubMed]
  • 14. Menzies D, Gardiner G, Farhat M, Greenaway C, Pai M. Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results. Int J Tuberc Lung Dis. 2008; 12(5): 498-505[PubMed]
  • 15. Grzybowski S, Allen EA. The Challenge of Tuberculosis in Decline. A Study Based on the Epidemiology of Tuberculosis in Ontario, Canada. Am Rev Respir Dis. 1964; 90: 707-20[PubMed]
  • 16. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med. 1999; 159(1): 15-21[DOI][PubMed]
  • 17. Bass JA, Jr, Serio RA. The use of repeat skin tests to eliminate the booster phenomenon in serial tuberculin testing. Am Rev Respir Dis. 1981; 123(4 Pt 1): 394-6[PubMed]
  • 18. Menzies D, Al Jahdali H, Al Otaibi B. Recent developments in treatment of latent tuberculosis infection. Indian J Med Res. 2011; 133: 257-66[PubMed]
  • 19. Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, Hopewell PC. release assays for active pulmonary tuberculosis diagnosis in adults in lowand middle-income countries: systematic review and metaanalysis. Infecti Dis J. 204(4)
  • 20. Bucher HC, Griffith LE, Guyatt GH, Sudre P, Naef M, Sendi P, et al. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS. 1999; 13(4): 501-7[PubMed]
  • 21. Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. The Lancet J. 2011; 377(9777): 1588-98[DOI]
  • 22. Trajman A, Steffen RE, Menzies D. Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence. Pulm Med. 2013; 2013: 601737[DOI][PubMed]
  • 23. Todryk SM, Pathan AA, Keating S, Porter DW, Berthoud T, Thompson F, et al. The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming. Immunology. 2009; 128(1): 83-91[DOI][PubMed]
  • 24. Sarrazin H, Wilkinson KA, Andersson J, Rangaka MX, Radler L, van Veen K, et al. Association between tuberculin skin test reactivity, the memory CD4 cell subset, and circulating FoxP3-expressing cells in HIV-infected persons. J Infect Dis. 2009; 199(5): 702-10[DOI][PubMed]
  • 25. Pollock NR, Campos-Neto A, Kashino S, Napolitano D, Behar SM. Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution? Infect Control Hosp Epidemiol. 2008; 29(9): 878-86[DOI][PubMed]
  • 26. Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A. Negative and positive predictive value of a whole-blood interferon-gamma release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med. 2011; 183(1): 88-95[DOI][PubMed]
  • 27. Horsburgh CR, Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004; 350(20): 2060-7[DOI][PubMed]
  • 28. Herrera V, Perry S, Parsonnet J, Banaei N. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis. 2011; 52(8): 1031-7[DOI][PubMed]
  • 29. Bianchi L, Galli L, Moriondo M, Veneruso G, Becciolini L, Azzari C, et al. Interferon-Gamma Release Assay Improves the Diagnosis of Tuberculosis in Children. Pediat Infect Dis J . 2009; 28(6): 510-4[DOI]
  • 30. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2011; 15(8): 1018-32[DOI][PubMed]
  • 31. Nenadic N, Kirin BK, Letoja IZ, Plavec D, Topic RZ, Dodig S. Serial interferon-gamma release assay in children with latent tuberculosis infection and children with tuberculosis. Pediatr Pulmonol. 2012; 47(4): 401-8[DOI][PubMed]
  • 32. Kim EY, Lim JE, Jung JY, Son JY, Lee KJ, Yoon YW. Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis. 2009; 9: 207[DOI][PubMed]
  • 33. Mardani M, Tabarsi P, Mohammadtaheri Z, Chitsaz E, Farokhzad E, Hadavand F. Performance of Quantiferon TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran. Ann Thorac Med. 2010; 5(1): 43-6
  • 34. Chang B, Park HY, Jeon K, Ahn JK, Cha HS, Koh EM, et al. Interferon-gamma release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. Clin Rheumatol. 2011; 30(12): 1535-41[DOI][PubMed]
  • 35. Mardani M, Farshidpour M, Nekoonam M, Varahram F, Najafizadeh K, Mohammadi N, et al. Performance of QuantiFERON TB gold test compared with the tuberculin skin test for detecting latent tuberculosis infection in lung and heart transplant candidates. Exp Clin Transplant. 2014; 12(2): 129-32[PubMed]
  • 36. Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, Coleman C, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2011; 56(3): 230-8[DOI][PubMed]
  • 37. Dheda K, van Zyl-Smit RN, Meldau R, Meldau S, Symons G, Khalfey H, et al. Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Thorax. 2009; 64(10): 847-53[DOI][PubMed]
  • 38. Ling DI, Pai M, Davids V, Brunet L, Lenders L. Are interferon-gamma release assays useful for diagnosing active tuberculosis in a high-burden setting? Eur Respir J. 2011; 38(3): 649-56[DOI][PubMed]
  • 39. Chee CB, Gan SH, Khinmar KW, Barkham TM, Koh CK, Liang S, et al. Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol. 2008; 46(6): 1935-40[DOI][PubMed]
  • 40. Leidl L, Mayanja-Kizza H, Sotgiu G, Baseke J, Ernst M, Hirsch C, et al. Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Respir J. 2010; 35(3): 619-26[DOI][PubMed]
  • 41. Markova R, Todorova Y, Drenska R, Elenkov I, Yankova M, Stefanova D. Usefulness of Interferon-Gamma Release Assays in the Diagnosis of Tuberculosis Infection in HIV-Infected Patients in Bulgaria. Biotech Equip J. 2014; 23(1): 1103-8[DOI]
  • 42. Bartalesi F, Vicidomini S, Goletti D, Fiorelli C, Fiori G, Bartoloni A. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J. 2009; 33(3): 586-93[DOI][PubMed]
  • 43. Behar SM, Shin DS, Maier A, Coblyn J, Helfgott S, Weinblatt ME. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy. J Rheumatol. 2009; 36(3): 546-51[DOI][PubMed]
  • 44. Bocchino M, Matarese A, Bellofiore B, Giacomelli P, Santoro G. Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment. Eur J Clin Microbiol Infect Dis. 2008; 27(10): 907-13[DOI][PubMed]
  • 45. Cobanoglu N, Ozcelik U, Kalyoncu U, Ozen S, Kiraz S, Gurcan N. Interferongamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers. Tuberc Lung Dis J. 2007; 11(11): 1177-82
  • 46. Gogus F, Gunendi Z, Karakus R, Erdogan Z, Hizel K, Atalay F. Comparison of tuberculin skin test and QuantiFERON-TB gold in tube test in patients with chronic inflammatory diseases living in a tuberculosis endemic population. Clin Exp Med. 2010; 10(3): 173-7[DOI][PubMed]
  • 47. Kleinert S, Kurzai O, Elias J, Marten K, Engelke C, Feuchtenberger M, et al. Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases. Ann Rheum Dis. 2010; 69(4): 782-4[DOI][PubMed]
  • 48. Kwakernaak AJ, Houtman PM, Weel JF, Spoorenberg JP, Jansen TL. A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor alpha inhibitor. Clin Rheumatol. 2011; 30(4): 505-10[DOI][PubMed]
  • 49. Laffitte E, Janssens JP, Roux-Lombard P, Thielen AM, Barde C, Marazza G, et al. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test. Br J Dermatol. 2009; 161(4): 797-800[DOI][PubMed]
  • 50. Marques CD, Duarte AL, de Lorena VM, Souza JR, Souza WV, Gomes Yde M, et al. Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis. Rheumatol Int. 2009; 30(1): 57-62[DOI][PubMed]
  • 51. Martin J, Walsh C, Gibbs A, McDonnell T, Fearon U, Keane J, et al. Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis. Ann Rheum Dis. 2010; 69(1): 181-5[DOI][PubMed]
  • 52. Matulis G, Juni P, Villiger PM, Gadola SD. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis. 2008; 67(1): 84-90[DOI][PubMed]
  • 53. Chiappini E, Della Bella C, Bonsignori F, Sollai S, Amedei A, Galli L, et al. Potential role of M. tuberculosis specific IFN-gamma and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis. PLoS One. 2012; 7(9)[DOI][PubMed]
  • 54. Schoepfer AM, Flogerzi B, Fallegger S, Schaffer T, Mueller S, Nicod L, et al. Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease. Am J Gastroenterol. 2008; 103(11): 2799-806[DOI][PubMed]
  • 55. Vassilopoulos D, Stamoulis N, Hadziyannis E, Archimandritis AJ. Usefulness of enzyme-linked immunosorbent assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Addendum. Rheumat J. 2008; 35(7): 1464
  • 56. Smith R, Cattamanchi A, Steingart KR, Denkinger C, Dheda K, Winthrop KL, et al. Interferon-gamma release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders. Curr Opin Rheumatol. 2011; 23(4): 377-84[DOI][PubMed]
  • 57. Mazurek GH, Jereb JA, Vernon A, LoBue P, Goldberg S, Castro KG, et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection, United States, 2010. 2010;
  • 58. Okada K, Mao TE, Mori T, Miura T, Sugiyama T, Yoshiyama T, et al. Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children. Epidemiol Infect. 2008; 136(9): 1179-87[DOI][PubMed]
  • 59. Petrucci R, Abu Amer N, Gurgel RQ, Sherchand JB, Doria L, Lama C, et al. Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatr Infect Dis J. 2008; 27(12): 1073-7[DOI][PubMed]
  • 60. Thomas TA, Mondal D, Noor Z, Liu L, Alam M, Haque R, et al. Malnutrition and helminth infection affect performance of an interferon gamma-release assay. Pediatrics. 2010; 126(6)-9[DOI][PubMed]
  • 61. Choi JC, Shin JW, Kim JY, Park IW, Choi BW, Lee MK. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection. Chest. 2008; 133(6): 1415-20[DOI][PubMed]
  • 62. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, Lugos MD, et al. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med. 2007; 4(6)[DOI][PubMed]
  • 63. Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 2012; 9(7)[DOI][PubMed]
  • 64. Worjoloh A, Kato-Maeda M, Osmond D, Freyre R, Aziz N, Cohan D. Interferon gamma release assay compared with the tuberculin skin test for latent tuberculosis detection in pregnancy. Obstet Gynecol. 2011; 118(6): 1363-70[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments